Physician profile
Michael E Maddox
NPI 1083692115
$23,634.38
in general payments reported to CMS, 2019-2025
52 companies · $2,655 in 2025
The $2,655 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,083 · 2020: $2,775 · 2021: $3,524 · 2022: $3,820 · 2023: $4,945 · 2024: $2,834 · 2025: $2,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,858 · Travel and Lodging: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,857.63 |
| Travel and Lodging | $1,575.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,581.27 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $2,249.27 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boston Scientific Corporation | $2,143.05 | 2020-2025 | Watchman Access System, Watchman Flx |
| Pfizer INC. | $2,056.91 | 2019-2025 | |
| Lilly USA, LLC | $1,787.17 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,535.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,329.87 | 2021-2025 | |
| Abbott Laboratories | $821.83 | 2019-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $788.12 | 2022-2025 | |
| Amgen INC. | $767.14 | 2019-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $707.76 | 2019-2025 | Jardiance, Ofev |
| Janssen Pharmaceuticals, INC | $641.50 | 2019-2025 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $587.32 | 2019-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $538.84 | 2019-2022 | |
| Amarin Pharma, INC. | $467.39 | 2019-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $420.63 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $373.28 | 2019-2022 | |
| Axsome Therapeutics, INC. | $365.08 | 2023-2025 | Auvelity, Sunosi |
| Kowa Pharmaceuticals America, INC. | $361.27 | 2019-2023 | Livalo, Seglentis |
| Esperion Therapeutics, INC. | $340.41 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $319.48 | 2019-2022 | |
| Astellas Pharma US INC | $244.69 | 2019-2024 | Veozah |
| Allergan, INC. | $223.53 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $215.41 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $210.61 | 2019-2023 | |
| Exact Sciences Corporation | $199.31 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $195.26 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company Ltd. | $180.74 | 2022 | |
| Currax Pharmaceuticals LLC | $121.52 | 2020-2023 | Contrave |
| Idorsia Pharmaceuticals US INC | $100.33 | 2022-2023 | Quviviq |
| Almatica Pharma LLC | $97.65 | 2024-2025 | Loreev Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $80.84 | 2024-2025 | Caplyta |
| Lundbeck LLC | $72.68 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $65.35 | 2019-2020 | |
| Genentech USA, INC. | $59.70 | 2019-2021 | |
| Biogen, INC. | $51.04 | 2021-2022 | |
| Dynavax Technologies Corporation | $37.98 | 2021-2024 | Heplisav-B |
| Intra-Sana Laboratories | $33.98 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Sanofi Pasteur INC. | $33.95 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $25.45 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.64 | 2024 | Rexulti |
| Inspire Medical Systems, INC. | $21.08 | 2025 | Inspire |
| Azurity Pharmaceuticals, INC. | $20.19 | 2025 | |
| Althera Pharmaceuticals LLC | $17.80 | 2021-2022 | |
| Eisai INC. | $16.84 | 2020 | |
| Phathom Pharmaceuticals, INC. | $16.26 | 2024 | Voquezna |
| Avanir Pharmaceuticals, INC. | $15.54 | 2021 | |
| Pharmacosmos Therapeutics INC. | $15.03 | 2024 | Monoferric |
| Inari Medical, INC. | $14.96 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Arbor Pharmaceuticals, INC. | $13.30 | 2021 | |
| Aytu Biopharma, INC. | $13.22 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.